Menu
US
htrf-foxo1-1920x400
Application Note

FOXO1 in Non-Alcoholic Fatty Liver Disease

HTRF™ application note

Non-alcoholic fatty liver disease (NAFLD) includes a range of liver conditions unrelated to alcohol consumption that results in inflammation and fibrosis. NAFLD may progress to non-alcoholic steatohepatitis (NASH), cirrhosis, or liver failure; and is closely linked to metabolic syndromes through activation of glucose and lipogenesis-regulating transcription factors, such as FOXO1.

Download this complimentary application note to explore the use of an HTRF assay for the evaluation of FOXO1 in a fatty liver disease model and evaluate:

  • Pro-inflammatory cytokine activation
  • The benefits of HTRF assays compared to western blot
  • A model system for fatty liver disease and insulin resistance

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

FOXO1 in Non-Alcoholic Fatty Liver Disease

Download Application Note